Manuel Ugarte-Gil to Severity of Illness Index
This is a "connection" page, showing publications Manuel Ugarte-Gil has written about Severity of Illness Index.
Connection Strength
0.289
-
Better Health-Related Quality of Life in Systemic Lupus Erythematosus Predicted by Low Disease Activity State/Remission: Data From the Peruvian Almenara Lupus Cohort. Arthritis Care Res (Hoboken). 2020 08; 72(8):1159-1162.
Score: 0.116
-
Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort. J Rheumatol. 2019 10; 46(10):1299-1308.
Score: 0.106
-
Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus. Lupus. 2018 May; 27(6):913-919.
Score: 0.024
-
Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL). Ann Rheum Dis. 2017 Dec; 76(12):2071-2074.
Score: 0.024
-
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Ann Rheum Dis. 2021 09; 80(9):1137-1146.
Score: 0.008
-
Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohort. Semin Arthritis Rheum. 2017 10; 47(2):199-203.
Score: 0.006
-
Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients. Clin Rheumatol. 2017 Apr; 36(4):845-852.
Score: 0.006